Calcineurin Inhibitors: Tacrolimus and Pimecrolimus
Calcineurin inhibitors, specifically tacrolimus and pimecrolimus, are topical immunomodulators used primarily in the treatment of inflammatory skin disorders such as atopic dermatitis. They work by inhibiting T-cell activation and cytokine release, providing an alternative to topical corticosteroids with a favorable side effect profile.
Topics: tacrolimus, pimecrolimus, steroid-sparing
Overview / Definition Calcineurin inhibitors (CNIs) are a class of medications that modulate the immune response and are commonly used in dermatology for the treatment of inflammatory skin conditions. The two most widely used CNIs are tacrolimus and pimecrolimus, which are primarily indicated for atopic dermatitis, especially in sensitive areas where the use of topical corticosteroids may pose a risk of skin atrophy. Epidemiology Atopic dermatitis affects approximately 10-20% of children and 1-3% of adults worldwide. Its prevalence is increasing, and it is often associated with other atopic conditions such as asthma and allergic rhinitis. Tacrolimus and pimecrolimus are particularly beneficial for patients with moderate to severe atopic dermatitis, especially those who do not tolerate or respond adequately to topical steroids. Pathophysiology / Mechanism The underlying pathophysiology of atopic dermatitis involves a complex interplay of genetic, environmental, and immunological factors. Inflammation is driven by an imbalance of T-helper 2 (Th2) and T-helper 1 (Th1) cells, leading to overproduction of cytokines such as IL-4, IL-5, and IL-13. Tacrolimus and pimecrolimus act by inhibiting the enzyme calcineurin, which plays a crucial role in T-cell activation. By preventing the dephosphorylation of nuclear factor of activated T cells (NFAT), these medications reduce the production of pro-inflammatory cytokines. Clinical Presentation Patients with atopic dermatitis typically present with: Pruritic, erythematous, and dry skin lesions Lesions often located on flexural surfaces (elbows, knees) and face in children Chronic lichenification in long-standing cases Associated features of atopy such as asthma or allergic rhinitis Diagnosis / Workup The diagnosis of atopic dermatitis is primarily clinical, based on history and examination. Key aspects include: Assessing family and personal history of atopy Evaluating the distribution and morphology of skin lesions Exclusion of ot